Safety and Efficacy of BKM120 in Relapsed and Refractory NHL

NCT01693614 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma

Interventions

DRUG: Buparlisib

Sponsor

Novartis Pharmaceuticals